Overview
This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).
Eligibility
Inclusion Criteria:
- • Age ≥ 21 years
- Vital teeth
- Sufficient tooth structure for veneer retention
- Willing and able to provide written informed consent
- Ability to attend all follow-up appointments
- Adequate oral hygiene as determined by the investigator
Exclusion Criteria:
- • Patients with active periodontal disease (probing depth > 4mm, bleeding on
probing)
- Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination)
- Poor oral hygiene (plaque index > 30%)
- Pregnancy or nursing
- Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression)
- Known allergies to study materials (ceramic, or resin cement components)
- Inability to comply with study requirements
- Current participation in other dental clinical trials
- Active orthodontic treatment